Norethindrone And Ethinyl Estradiol Kit
Product Images NDC 60505-4901

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norethindrone And Ethinyl Estradiol (NDC 60505-4901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nor-ethi-str (Nor Ethi Str)

Chemical structure diagrams of the active ingredients norethindrone and ethinyl estradiol, the components of the prescription drug kit by Apotex Corp. Each structure shows the molecular arrangement and bonds of the respective hormone compounds.*

FDA Label Image

Nor-ethi-fig1 (Nor Ethi Fig1)

A bar chart showing mortality rates (number of deaths per 100,000 woman-years) by age group (15-24, 25-34, 35-44, 45-) and smoking status for ever users and controls. The chart compares non-smokers and smokers within ever users and controls, demonstrating increasing mortality rates with age, notably higher for ever users who smoke in the older age groups.*

FDA Label Image

Figure2 (Figure2)

A forest plot depicting the risk of breast cancer associated with combined oral contraceptive use from several studies between 2002 and 2017. The effect estimates (odds ratios/relative risks) and confidence intervals are shown for ever and current use across study populations, with values ranging from 0.9 to 1.3, centered around 1.0 on the x-axis representing no increased risk.*

FDA Label Image

Blister-1 (Blister 1)

An instructional diagram for Norethindrone and Ethinyl Estradiol Tablets, USP 1 mg/0.035 mg 28-day kit by Apotex Corp. It shows a 4-week pill pack layout with empty circular daily pill slots labeled by day of the week and week number. A hand is depicted placing a day label over the pill slots, with guidance to peel and place the label correctly for daily use.*

FDA Label Image

Blister-2 (Blister 2)

Norethindrone and Ethinyl Estradiol Tablets, USP 1 mg/0.035 mg, 28-Day oral tablet kit packaging label from Apotex Corp. The label shows a blister pack layout with a 4-week, 7-day per week format with blank tablet slots arranged in rows labeled Week 1 to Week 4 and days from Sunday to Saturday, indicating a typical birth control daily dose schedule. It includes handling instructions for placing day labels and a barcode on the right side.*

FDA Label Image

Blister-3 (Blister 3)

An instructional diagram showing how to apply a day label to a 28-day oral contraceptive kit for Norethindrone and Ethinyl Estradiol Tablets, USP 1 mg/0.035 mg by Apotex Corp. The image depicts a hand peeling and placing a day label along the top row of circular tablet slots organized by weeks and weekdays, with instructions to place the correct day label starting from Sunday.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.